These COVID-19 clinical trials are active and approved by Health Canada. Many more are pending approval and will be added in the days and weeks ahead.
Help us complete the circle. Add your trial to our list of active COVID-19 Canadian clinical trials and gain access to a wider participant registry.
To see if dapagliflozan will prevent serious complications and death in people who are hospitalized with COVID-19. Study participants will receive dapagliflozan or placebo.
To assess the effectiveness and safety of ruxolitinib in the treatment of adult patients with COVID-19 pneumonia.